Drugs / GCSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02579005 Background | Apr 2018 → Oct 2024 | lung cancer | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCSF | “Donors will receive 5 daily doses of GCSF, 10 µg/kg, by subcutaneous injection from Day -4.” NCT02579005 ↗ |